Prognosis
Europe May Race the U.S. for Early Vaccine Access With Deals
- EU’s executive seeks mandate to negotiate with drugmakers
- Proposal subject to approval by EU’s national governments
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
The European Union is looking to join the global race to secure early access to future coronavirus vaccines, seeking deals to share the cost of development with pharmaceutical companies.